Company News in the Life Science Industry

»

Reset 

Honor The Veterinary Heroes In Your Animal's Life!

WASHINGTON, Jan. 16, 2019 /PRNewswire/ -- For millions of Americans, animals are not just their best friends, but their heroes. Whether they are lending eyes to the unsighted, ears to the deaf, protection to the sleeping family and the soldier, or providing a welcoming lick at the end of a hard... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Survey Questions Cancer Doctors' Awareness of LGBTQ Issues

BROOKLYN, N.Y., Jan. 16, 2019 /PRNewswire/ -- Most oncologists say they don't know enough about how to treat patients with differences in sexual orientation or identity, but most are also interested in learning more, a new study finds.

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  NYU Langone Health | NYU Langone Medical Center- Cytometry & Cell Sorting Laboratory

New INGREZZA® (valbenazine) Analysis Published in the Journal of Affective Disorders Demonstrates Sustained Improvement in Tardive Dyskinesia Symptoms in Patients with Primary Mood Disorders

SAN DIEGO, Jan. 16, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that a new analysis of INGREZZA(®) (valbenazine) capsules, published in the Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  Neurocrine Biosciences, Inc.

Mirati Therapeutics Announces Proposed Public Offering Of Common Stock

SAN DIEGO, Jan. 16, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell, subject to market and other conditions, $75.0 million of shares of its common stock in an underwritten public offering. Mirati expects to grant the underwriters... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  Mirati Therapeutics, Inc.

Sandoz Inc. launches SYMJEPI(TM) (epinephrine) in the US

PRINCETON, N.J., Jan. 16, 2019 /PRNewswire/ -- Sandoz Inc. (Sandoz), a Novartis division, today announced the US market introduction of SYMJEPI(TM) (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis. Sandoz is launching this medicine... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Omron® HeartGuide(TM), the first wearable blood pressure monitor, a top award-winner at CES 2019

LAKE FOREST, Ill., Jan. 16, 2019 /PRNewswire/ -- Omron Healthcare, the global leader in personal heart health and wellness technology, has received global media recognition and top awards - including best wearable, best health tech, and a top innovation pick - at the international Consumer Electronics... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Actelion Receives Complete Response Letter from U.S. FDA for OPSUMIT® (Macitentan) Supplemental New Drug Application

SOUTH SAN FRANCISCO, Calif., Jan. 16, 2019 /PRNewswire/ -- Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Protagonist Therapeutics Reports Granting of Inducement Award

NEWARK, Calif., Jan. 16, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on Jan. 15, 2019, it issued an inducement award to Suneel Gupta, Ph.D., the Company's recently hired Executive Vice President of Clinical Operations and Pharmacology, in accordance with... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  Protagonist Therapeutics Inc.

The global medical imaging workstations market is projected to reach USD 1,377 million by 2023 from USD 897 million in 2018, at a CAGR of 8.9%

NEW YORK, Jan. 16, 2019 /PRNewswire/ -- The medical imaging workstations market is projected to grow at a CAGR of 8.9%
The global medical imaging workstations market is projected to reach USD 1,377 million by 2023 from USD 897 million in 2018, at a CAGR of 8.9%. Factors such as the... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY(TM) (romosozumab)

THOUSAND OAKS, Calif. and BRUSSELS, Jan. 16, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced strong support from the U.S. Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) for the approval of EVENITY(TM)*... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  Amgen, Inc.

Cryopreservation company, Acorn Biolabs closes $3.3M seed funding and ramps towards consumer launch

The world's first non-invasive home-cell collection service will allow consumers to easily collect live cells for future therapeutic uses.

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  Acorn Biolabs

FDA Grants Cerecor’s Three Substrate Replacement Therapies Orphan Drug Designation

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019
Related companies:  Cerecor Inc.

With Danish Advancements, ICC Gears Up for Key Role in European Supply Chain -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019

Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019
Related companies:  Aptinyx Inc.

HomeCare Elite Honors 166 Amedisys Home Health Care Centers

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019
Related companies:  Amedisys

Sport Endurance to Reincorporate as Better Choice Company, Inc.

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019

Cue Biopharma Announces Presentation Highlighting Immuno-STAT Platform and CUE-101 at the 2019 Keystone Symposia Conference

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019
Related companies:  Cue Biopharma

Fibrocell to Present at Phacilitate Leaders World 2019

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019
Related companies:  Fibrocell Science Inc.

VBI Vaccines Appoints Blaine McKee to Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019
Related companies:  VBI Vaccines Inc.

Loos, France, RLG Headquarter, January 15th 2019: Radiopharma Logistics Group (RLG); Isotopes Service International restructuring successfully completed, 11 Million treated patients, thanks to RLG in 2018.

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jan 2019
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies